Pattern Bioscience
PrivateLast Round
Series D
Nov 18, 2025
Total Funding Raised
$131.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pattern Bioscience is a biotechnology company that develops rapid, culture-free diagnostic technologies for identifying bacterial infections and determining antibiotic susceptibility.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pattern Bioscience Comparables
Compare Pattern Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeLux Diagnostics | 85% | |
| Gradientech | 84% | |
| Resistell AG | 83% |
Pattern Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 18, 2025 | ||||
| Grant | Nov 21, 2024 | ||||
| Series C | Apr 27, 2023 | ||||
| Series B Extension | Jul 14, 2020 | ||||
| Series B | Feb 4, 2020 | ||||
Grant | Feb 4, 2020 |
Key People
Founding team and executive leadership
Pattern Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series C, Series D |
| CARB-X | Grant |
| NIH RADx | Grant |
| Omnimed Capital | Series B Extension, Series C |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| National Institutes of Health (NIH) | Grant |
| Illumina Ventures | Series B Extension, Series C, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 306% MoM, reaching 15.1K.
- Mar 1, 2026
Implementing NetSuite for production and order-to-cash cycle.
Recent news
Latest coverage and updates
- hiresJul 27, 2026
Pattern Bioscience, Inc. hired David Barreca as Vice President of Sales on Jul 27th '26.
Pattern Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pattern Bioscience's valuation, stock price, and market status.
Is Pattern a public or private company?
Pattern is a private company.
What is the current stock price of Pattern?
Pattern is a private company with no public stock price. No recent secondary market data is available.
How much is Pattern worth (valuation)?
Valuation information for Pattern is not publicly available.
Can I buy Pattern stock?
Pattern shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pattern's last funding round?
Pattern's most recent funding round was Series C on April 27, 2023.
Who are the main investors in Pattern?
Key investors in Pattern include Omnimed Capital, Illumina Ventures.
Will Pattern IPO soon?
No public IPO plans have been announced for Pattern.
How can I track Pattern secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pattern's secondary market activity and sign up for updates.